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Streptococcus agalactiae, or Group B Streptococcus (GBS), is a gram-positive
bacterial pathogen associated with infection during pregnancy and is a major
cause of morbidity and mortality in neonates. Infection of the extraplacental
membranes surrounding the developing fetus, a condition known as chorioamnionitis,
is characterized histopathologically by profound infiltration of polymorphonuclear cells
(PMNs, neutrophils) and greatly increases the risk for preterm labor, stillbirth, or neonatal
GBS infection. The advent of animal models of chorioamnionitis provides a powerful
tool to study host-pathogen relationships in vivo and ex vivo. The purpose of this
study was to evaluate the innate immune response elicited by GBS and evaluate how
antimicrobial strategies elaborated by these innate immune cells affect bacteria. Our
work using a mouse model of GBS ascending vaginal infection during pregnancy reveals
that clinically isolated GBS has the capacity to invade reproductive tissues and elicit
host immune responses including infiltration of PMNs within the choriodecidua and
placenta during infection, mirroring the human condition. Upon interacting with GBS,
murine neutrophils elaborate DNA-containing extracellular traps, which immobilize GBS
and are studded with antimicrobial molecules including lactoferrin. Exposure of GBS to
holo- or apo-forms of lactoferrin reveals that the iron-sequestration activity of lactoferrin
represses GBS growth and viability in a dose-dependent manner. Together, these data
indicate that the mouse model of ascending infection is a useful tool to recapitulate
human models of GBS infection during pregnancy. Furthermore, this work reveals that
neutrophil extracellular traps ensnare GBS and repress bacterial growth via deposition
of antimicrobial molecules, which drive nutritional immunity via metal sequestration
strategies.
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INTRODUCTION
GBS and Pregnancy
Streptococcus agalactiae (Group B Streptococcus, GBS) is a leading
cause of adverse pregnancy and neonatal outcomes including
stillbirth, chorioamnionitis, preterm birth, and neonatal sepsis
and meningitis (Verani et al., 2010; Koumans et al., 2012; Kwatra
et al., 2014; Kim et al., 2015). While up to 50% of pregnant
women screen positive for GBS rectovaginal colonization at some
point during pregnancy, most women maintain asymptomatic
colonization (Kwatra et al., 2014). However, in some neonates,
invasive GBS disease occurs via vertical transmission either from
ascending vaginal infection during pregnancy or from exposure
during vaginal delivery, resulting in lifelong health impairments
for affected children (McNamara et al., 1997; Verani et al., 2010;
Koumans et al., 2012; Kwatra et al., 2014; Kim et al., 2015).
Consequently, the CDC recommends routine GBS screening
during late pregnancy and antibiotic prophylaxis for those testing
positive (Koumans et al., 2012). Despite this intervention, GBS
remains the leading infectious cause of morbidity and mortality
among neonates in the United States (Verani et al., 2010).
Chorioamnionitis and Neutrophils
Ascending bacterial infection from the lower genital tract
to the uterine cavity is the most common cause of intra-
amniotic infection, which leads to profound inflammation
of the extraplacental membranes surrounding the fetus; a
process that is termed chorioamnionitis (McNamara et al.,
1997; Kim et al., 2015). Ascending microorganisms are first
localized in the supracervical decidua; subsequent propagation
and chorioamniotic passage leads to microbial infection of the
amniotic cavity and even the fetus (Kim et al., 2015). Microbial
invasion of the amniotic cavity has been shown to induce a
robust inflammatory response including an increase in pro-
inflammatory cytokines such as IL-1, TNF-alpha, IL-6, and IL-
8, as well as a dramatic increase in neutrophil count (Kim
et al., 2015). Histopathologically, the characteristic morphologic
feature of acute chorioamnionitis is diffuse infiltration of
neutrophils ofmaternal origin into the extraplacentalmembranes
(McNamara et al., 1997; Gravett et al., 2004; Kim et al., 2015).
Neutrophils and Extracellular Traps
Colonization of the female genital tract by potential pathogens
is a complex process influenced by the host innate immune
response and the pathogenic potential of the invading microbe.
GBS is distinctive in its ability to cause both invasive disease
and asymptomatic colonization of the female genital tract
(Goldenberg et al., 2008). GBS is an important pathogen that
causes invasive disease in pregnant hosts. In an effort to
study how GBS colonizes the reproductive tract and causes
ascending invasion of gestational tissues, we employed a mouse
model of ascending GBS vaginal infection during pregnancy
which was pioneered by Randis et al. (2014). Studies in this
model have shown that the GBS toxin beta-hemolysin/cytolysin
directly induced disruption of maternal-fetal barriers, causing
chorioamnionitis, preterm birth, and stillbirth (Randis et al.,
2014). Furthermore, studies of a murine model of chronic GBS
genital tract colonization showed significant neutrophil infiltrates
in the vaginal mucosa and the formation of DNA neutrophil
extracellular traps (NETs) in response to GBS infection (Carey
et al., 2014). Human neutrophils have also been shown to form
NETs in vitro in response to GBS (Carey et al., 2014). NETs
are a recently discovered antimicrobial mechanism composed
of nuclear chromatin, histones, and other antimicrobial proteins
that serve to immobilize and kill or inhibit the growth of invading
microbes (Brinkmann et al., 2004).
Neutrophils and Nutritional Immunity
High resolution imaging studies have revealed that the DNA
which comprises NETs is studded with antimicrobial proteins
such as myeloperoxidase, elastin, calprotectin (S100A8/S100A9
heterodimer) and lactoferrin (Brinkmann et al., 2004). The
latter two of these host proteins bind transition metals
such as manganese, zinc, and/or iron at high affinity to
effectively sequester these important nutrients away from
invading pathogens in a process referred to as “nutritional
immunity” (Becker and Skaar, 2014). Proteomic analyses of
amniotic fluid from cases of intra-amniotic infection have
revealed dramatic changes in protein composition and increased
presence of neutrophil-associated antimicrobial proteins, such
as lactoferrin (Gravett et al., 2004; Kim et al., 2015). Previous
work indicates that GBS has a strict requirement for iron
to initiate bacterial growth in a chemically defined medium
(Mickelson, 1966; Willett and Morse, 1966). This, coupled with
the observation that lactoferrin is elevated in GBS-infected
tissues where neutrophils are abundant (Gravett et al., 2004; Kim
et al., 2015), led us to hypothesize that neutrophilic infiltrates,
which are characteristically present in chorioamnionitis, could
potentially be controlling GBS growth and proliferation in the
host by elaborating NETs studded with lactoferrin to chelate
nutrient iron and starve invading GBS of essential iron. Our
work demonstrates that neutrophils are recruited to the site of
GBS infection in a murine model of ascending infection during
pregnancy. Furthermore, we demonstrate that GBS-neutrophil
interaction results in the elaboration of NETs decorated with the
antimicrobial protein lactoferrin. In its apo- (unbound to iron)
form, lactoferrin inhibits GBS growth and proliferation in a dose-
dependent manner that can be abrogated by the presence of an
exogenous source of nutrient metal.
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
The capsular type V S. agalactiae strain GB037, obtained from a
human case of neonatal sepsis (Davies et al., 2001), was cultured
on tryptic soy agar plates supplemented with 5% sheep blood
(blood agar plates) at 37◦C in ambient air overnight. Bacteria
were sub-cultured from blood agar plates into Todd-Hewitt broth
(THB) and incubated (aerobically, shaking at 200 RPM) at 37◦C
in ambient air overnight. The following day, bacterial density
was measured spectrophotometrically at an optical density of
600 nm (OD600), and bacterial numbers were determined with
a coefficient of 1 OD600 = 10
9 CFU/mL.
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Ethics Statement
All animal experiments were performed in accordance with
the Animal Welfare Act, U.S. federal law, and NIH guidelines.
All experiments were carried out under a protocol approved
by Vanderbilt University Institutional Animal Care and
Use Committee (IACUC; M/14/034), a body that has been
accredited by the Association of Assessment and Accreditation
of Laboratory Animal Care (AAALAC).
Mouse Model of GBS Infection during
Pregnancy
GBS infection of pregnant mice and subsequent analyses were
performed as previously described with some modifications
(Randis et al., 2014). Experimental design is outlined in
Figure 1. Briefly, C57BL6/J mice were purchased from Jackson
Laboratories and mated in harem breeding strategies overnight.
Pregnancy was confirmed the following day by the presence of a
mucus plug to establish the embryonic date (E0.5). On embryonic
day 13 (E13.5) dams were anesthetized using isoflurane chambers
and 50 µL of inocula containing 103 colony forming units
(CFU) in THB medium plus 10% gelatin was introduced into
the vagina. Sham controls were inoculated with 50 µL of
THB medium containing 10% gelatin. Animals were housed
singly until embryonic day 15 (E15.5) at which time they were
sacrificed by carbon dioxide euthanasia procedures and necropsy
was performed to isolate reproductive tissues including vagina,
uterus, placenta, decidua, and fetus. For burden studies, a single
tissue sample was derived from each separate dam. Four to six
animals were utilized for each experimental group derived from
three separate experiments (sham treated uninfected animals
FIGURE 1 | Schematic representation of experimental design for
mouse model of ascending GBS infection during pregnancy. Pregnant
dams were vaginally inoculated with 103 CFU GBS on embryonic day 13.5.
Animals were sacrificed and tissues were analyzed 48-h post-infection, on
embryonic day 15.5.
or GBS-infected animals). Tissues were analyzed for bacterial
burden by enumerating CFU per mg of tissue by homogenizing
tissues, performing serial dilution, and quantitative culture on
blood agar plates.
Immunohistochemistry and
Histopathological Examination
Murine tissues (1 tissue sample per dam) from the GBS ascending
vaginal infection during pregnancy model were fixed in 10%
neutral buffered formalin prior to embedment in paraffin. Tissues
were cut into 5 µm sections and multiple sections were placed
on each slide for analysis. For histopathological examination,
sections were stained with hematoxylin and eosin and evaluated
by microscopical techniques. Additional sections of fetal-
placental tissue were evaluated by immunohistochemical (IHC)
techniques to determine the presence and spatial localization
of GBS or lactoferrin. After quenching with 0.03% hydrogen
peroxide for 20 min at RT, tissues were treated with a
heat-induced epitope retrieval solution (Universal decloacker,
Biocare Medical, Concord, CA) using a pressure cooker at
121◦C for 20 min and allowed to cool at RT prior to
blocking with 10% normal goat serum in PBS pH 7.4 0.1M.
Primary antibody, either a rabbit polyclonal antibody to
GBS (Abcam, ab78846) or a mouse monoclonal antibody to
lactoferrin (Abcam, ab166803), was applied for 1 h. Detection
of primary antibody was performed using the HRP-Polymer
system for 30 min and developed with 3, 3′-diaminobenzidine
tetrahydrochloride (DAB) (Dako, Carpinteria, CA). The sections
were counterstained with hematoxylin, rinsed, dehydrated, and
mounted with Cytoseal XYL before light microscopy analysis was
performed. Micrograph images were analyzed by ImageJ IHC
toolbox plugin to quantify H-DAB staining by color detection,
converted to 8-bit format and densitometry quantification as
previously described (Haley et al., 2015).
Flow Cytometry Evaluation of Neutrophils
Flow cytometry analyses were performed as previously described
with some modifications (Shynlova et al., 2013). Four to seven
placenta and decidua were collected from each animal (4–6
animals total) and pooled, weighed, minced with sterile scissors
and digested in a solution containing 1 mg/mL collagenase, 1
mg/mL hyaluronidase, and 150 µg/mL DNAse I with agitation
for 1 h at 37◦C. A total of 40 mL of digestion solution was used
per sample (each sample consisted of a single animal’s pooled
placenta or decidua, totaling 4–7 per animal) and samples were
washed using RPMI+/+medium (containing 1% antibiotic and
10% fetal bovine serum), centrifuged at 1500 RPM at 4◦C for
10 min followed by 100 µm nylon mesh filtration to eliminate
remaining particulates. Cells were then washed, as previously
described, and the filtrate was resuspended in 25% Percoll in
RPMI +/+, overlaid onto 50% Percoll, with 2 mL PBS layered
above the 25% Percoll. Percoll gradient was centrifuged for 35
min at 1500 RPM without the brake and cells were washed as
before, followed by 10 min at room temperature in RBC lysis
buffer (eBiosciences). After two more washes with RPMI +/+,
cells were counted and one million cells were aliquoted into flow
cytometry tubes. Cells were surface stained for 20min at 4◦Cwith
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anti-mouse CD45, anti-mouse CD11b, anti-mouse Neu7/4 (Ly-
6B.2), anti-mouse GR1 (1A8-Ly6g), and FcR blocking reagent.
Isotype controls were included in separate tubes. After surface
staining, all cells were washed with PBS and stained with a
live/dead viability dye (Life Technologies) for 30min at 4◦C. Cells
were then washed with 4 mL PBS containing 1% BSA (FACS
buffer), fixed for 15 min at 4◦C with 1% paraformaldehyde in
PBS, and washed again with FACS buffer. Cells were resuspended
in FACS buffer and immediately acquired on a BD LSR2 Flow
Cytometer (BD Biosciences). Analysis was performed with BD
FACS Diva software (BD Biosciences).
Elicitation and Isolation of Murine
Neutrophils
Murine neutrophils were prepared by peritoneal casein elicitation
protocol as previously described (Swamydas et al., 2015). Briefly,
C57BL6/J mice (both male and female) aged 6–10 weeks old were
purchased from Jackson Laboratories for these experiments.Mice
were anesthetized with isofluorane and 1 mL of sterile casein
solution (9% w/v in 1X PBS pH 7.2 containing 0.9 mM CaCl2
and 0.5 mM MgCl2) was injected into the peritoneal cavity of
each mouse (2–4 mice per experiment). The following day, a
second casein injection was performed and 4 h after the second
injection, mice were sacrificed and neutrophils were isolated
from the peritoneal cavity in 3–5 mL of sterile PBS. Cells were
collected and washed in 1X red blood cell lysis buffer (RBC Lysis
Buffer, Sigma Aldrich) before placing in RPMI 1640 medium
supplemented with 10% fetal bovine serum, L-glutamine, and
HEPES buffer. Validation of cell purity by flow cytometry
techniques described above reveals this protocol routinely yields
>95% pure neutrophil populations.
Confocal Laser Scanning Microscopy
Neutrophils isolated as described above were placed onto 12 mm
poly-L-lysine coated coverslips (ThermoFisher) and allowed to
adhere to the surface for 1 h before inoculation with bacterial
cells. Bacteria were added to neutrophils at a multiplicity of
infection of 50:1 and co-cultured for 24 h in the presence
or absence of 1 µg/mL of DNAse. Concomitantly, uninfected
samples were maintained as negative controls. Cells were stained
with 1 µM Sytox green (green, Life Technologies) and 30 nM
4′,6-diamidino-2-phenylindole (DAPI, blue, Life Technologies)
to target DNA, and mouse monoclonal antibody to lactoferrin
(Abcam, ab166803) plus secondary goat-anti-mouse antibody
conjugated to Alexa Fluor 647 (red) were applied to cells,
agitating for 1 h. Cells were washed with phosphate buffered
saline (pH 7.4) three times before mounting onto slides and
visualizing with a Zeiss LSM 710. Sytox green is an impermeable
dye which is used to stain extracellular traps and is also
used to differentiate between live and dead cells (Brinkmann
et al., 2010). DAPI stains condensed chromatin bright blue with
increased intensity proportional to chromatin condensation,
making it an efficient nuclear stain (Mascetti et al., 2001).
When used in combination, Sytox green will stain extracellular
DNA bright green, while DAPI stains nuclear chromatin blue.
However, in the case of samples evaluated for NETosis where
neutrophils frequently undergo cell death during the process,
Sytox green enters dying cells staining both the nucleus, and
the extracellular fibers green (resulting in co-staining of the
nucleus both blue and green). NETs were identified by Sytox
green staining of fibers extending outside of the cell nucleus
containing condensed chromatin (DAPI-positive, blue regions).
Images were analyzed in both widefield and confocal modalities
at 630X magnification and micrographs were collected with
Zen 2010 software. Micrographs shown are representative of
three biological replicates. Images were analyzed and statistical
analyses were performed with ImageJ and GraphPad Prism
software. A total of 151–192 cells were quantified for each
condition derived from more than 12 fields.
Field-Emission Gun Scanning Electron
Microscopy
Murine neutrophils isolated from the co-culture procedure
described above were prepared for scanning electron microscopy
analyses as previously described (Brinkmann et al., 2010).
Samples were subjected to washing three times with 0.05 M
sodium cacodylate buffer and fixing in 2.0% paraformaldehyde,
2.5% gluteraldehyde in 0.05 M sodium cacodylate buffer for 4 h.
Secondary fixation with 0.1% osmium tetroxide was performed
for 15 min prior to sequential dehydration with increasing
concentrations of ethanol. Samples were dried at the critical
point using a CO2 drier (Tousimis), mounted onto an aluminum
stub, and sputter-coated with 80/20 gold-palladium. A thin strip
of colloidal silver was painted at the sample edge to dissipate
sample charging. Samples were imaged with an FEI Quanta 250
field-emission gun scanning electron microscope (FEG-SEM).
Images are representative of three replicates from three different
experiments.
Preparation of Holo- or Apo-Lactoferrin
Iron-bound (holo-) or unbound (apo-) lactoferrin was prepared
as previously described (Senkovich et al., 2010). Briefly, 10 mM
stock of lactoferrin (Sigma Aldrich) was dialyzed against either
0.1 M sodium citrate-bicarbonate buffer pH 8.2 alone to generate
apo-lactoferrin, or buffer containing 70 mM ferric chloride to
generate holo-lactoferrin. Both apo- and holo-lactoferrin were
dialyzed against 1X phosphate buffered saline (PBS) containing
Chelex Resin (Sigma Aldrich) to remove any unbound iron
content.
Bacterial Growth and Viability Analyses
For growth and viability analyses, bacteria were cultured
overnight in THB (to an OD600 of ∼0.8), then sub-cultured by
performing a 1:100 dilution (roughly 8 × 106 CFU/mL) in 60%
THB plus 40% calprotectin buffer (100 mM NaCl, 3 mM CaCl2,
20 mM Tris pH 7.5; Senkovich et al., 2010; Haley et al., 2015)
referred to as “medium alone” or medium supplemented with
increasing concentrations (100, 250, 500, 750, 1000 µg/mL) of
purified apo- or holo-lactoferrin protein alone or supplemented
with 100 µM ferric chloride. These concentrations span the
physiological range at which lactoferrin would be present in
inflamed tissues and neutrophil granules (Masson et al., 1969;
Guillen et al., 1998; Simard et al., 2011). Additionally, bacteria
were grown in increasing concentrations of the synthetic chelator
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2, 2′-dipyridyl (25, 50, 100, 150, 200, 250, 300, 350, 400 µM)
in medium alone or medium supplemented with 250 µM ferric
chloride. Bacterial growth was evaluated at 24 h post-inoculation
by spectrophotometric reading of OD600 or bacterial viability was
evaluated at 24 h by serial dilution and plating onto blood agar
plates and quantifying viable colony forming units per mL of
culture (CFU/mL).
Statistical Analyses
Statistical analysis of flow cytometry and neutrophil NET
quantifications was performed using Student’s t-test and One-
Way ANOVA, respectively. Bacterial growth assays were
analyzed by One-Way ANOVA with either Tukey’s or Dunnet’s
post-hoc multiple correction tests and Student’s t-test. P ≤ 0.05
were considered significant. All data analyzed in this work
were derived from at least three separate biological replicates.
Statistical analyses were performed using GraphPad Prism
Software (Version 6.0, GraphPad Software Inc., La Jolla CA)
and Microsoft Excel (Version 14.6.3, Microsoft Corporation,
Redmond WA).
RESULTS
GBS Invades Gestational Tissues to Cause
Invasive Ascending Infection during
Pregnancy
To evaluate GBS ascending infection during pregnancy, we
utilized the mouse model of ascending GBS vaginal infection
as previously described (Randis et al., 2014) and developed
new outputs from this model by employing bacteriological
culturing and IHC microscopy assays to evaluate bacterial
burden in discrete tissue compartments within the gestational
tissue. Our results reveal that GBS colonizes surface of the
vagina (Supplemental Figure 1, Figure 2) at an average burden
of 3.6 × 106 CFU/mg of tissue, and the bacterial colonization
is spatially oriented at the lumen of the tissue within the
vaginal mucosa as determined by IHC microscopic examination
(Supplemental Figure 1). Furthermore, IHC microscopic
analyses reveal GBS ascends in this model and colonizes at
the lumen of the endometrium within the uterus, averaging
2.2 × 109 CFU/mg (Supplemental Figure 2). IHC analyses
also reveal that GBS invades the decidua and the placenta, and
quantitative culture demonstrates bacterial burden averages
8.5 × 108 CFU/mg in the decidua, 2.1 × 109 CFU/mg in the
placenta, and 3.3× 108 CFU/mg in the fetus.
GBS Infection Results in Profound
Inflammation Including Recruitment of
Neutrophils to the Placenta and the
Choriodecidua
Previous work indicates the murine model of ascending GBS
infection during pregnancy mirrors the human histopathological
changes associated with chorioamnionitis (McNamara et al.,
1997). In an effort to better characterize the inflammation
present within this model, we employed the immunological
tools readily available for utilization with this mouse model
FIGURE 2 | GBS invades reproductive tissues and disseminates in the
gravid host. Quantitative culture from tissues harvested from pregnant mice
infected with GBS reveals bacterial presence in numerous gestational tissues.
GBS bacteria ascend from the vagina to the uterus and invade the decidua,
placenta, and fetus (N = 4). Points represent burden value from 1 tissue
derived from 1 dam. Horizontal lines represent the geometric mean of bacterial
burden.
and performed both histopathological examination and
correlative flow cytometry analyses using antibodies to CD45,
Neu7/4, and GR1 which are specific for murine neutrophils
(Supplemental Figure 3) and CD45+/Neu7/4+/GR1+ gating
strategies. Histopathological examination reveals profound
infiltration of polymorphonuclear cells within GBS-infected
decidua and placenta, a result that was not seen in uninfected
samples (Figure 3). This result was recapitulated using flow
cytometry to analyze the placenta and decidua compartments,
demonstrating 54% of viable CD45+ cells were Neu7/4+/GR1+
neutrophils in GBS-infected placenta vs. 19% of uninfected
placenta, a significant increase in neutrophils infiltrating the
placenta in response to GBS infection (P < 0.05). Similarly,
61% of viable CD45+ cells were Neu7/4+/GR1+ neutrophils
in GBS-infected decidua vs. 16% of uninfected decidua, a
significant increase in neutrophils in the decidual compartment
in response to GBS infection (Figure 4, P < 0.05). Furthermore,
the preponderance of PMNs discovered in the decidual
and placental compartment is associated with GBS staining,
indicating neutrophils were recruited to the site of GBS infection
within each tissue compartment.
Lactoferrin Is Associated with Neutrophils
in the Decidua and Placenta in Response
to GBS Infection
Neutrophils play an important role in innate immunity against
bacterial pathogens. One way they accomplish this is by
secreting molecules with antimicrobial activity. Previous work
has shown that lactoferrin is elevated in patients with intra-
amniotic infections during pregnancy, disease states that are
often associated with high proportions of neutrophilic infiltration
of both the decidua and the placenta (McNamara et al., 1997;
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FIGURE 3 | Immunopathological analyses of fetal-placental units. Hematoxylin and eosin (H&E) stained samples of uninfected (A–F) and GBS-infected (G–L)
fetal-placental units reveal profound infiltration of polymorphonuclear cells in response to infection (K, black arrows), a result that was not observed in uninfected
animals (E). IHC analyses using a polyclonal rabbit antibody to total GBS cell lysate (α-GBS) indicate GBS penetrates the decidua and the placenta to invade the
gestational tissues (H,J,L, white arrows), a result that was not seen in uninfected animals (B,D,F). GBS staining is found within tissue compartments containing
polymorphonuclear cell infiltrates indicating neutrophils are present at the site of infection (representative images of N = 3–5).
FIGURE 4 | Flow cytometry analyses of placenta and decidua to
evaluate the relative abundance of neutrophils. Neutrophils were
evaluated by CD45+ Neu7/4+ GR1+ gating strategy on cells derived from the
placental or decidual compartment of uninfected or GBS-infected pregnant
mice. Bars represent mean percent (viable cells CD45+ Neu7/4+ GR1+) ±
SEM. GBS-infection results in enhanced presence of neutrophils in the
decidua and placenta (*P < 0.05 Student’s t-test, N = 4–6).
Gravett et al., 2004; Kim et al., 2015). We hypothesized that
neutrophils recruited to the site of GBS infection could produce
lactoferrin as an antimicrobial strategy. To test this, IHC analyses
were employed to determine the spatial localization of lactoferrin
within GBS-infected or uninfected gestational tissues (Figure 5).
Lactoferrin was highly abundant within the decidua and placenta
of GBS-infected pregnant mice, a result that was not observed
in uninfected control animals. Interestingly, lactoferrin staining
was largely associated with areas of tissue exhibiting profound
neutrophilic infiltrates (Figures 5G,H), and tissue compartments
that stain positive by IHC for GBS in, indicating this protein
could be associated with neutrophils which are found at the site
of GBS infection.
Neutrophils Encountering GBS Produce
Extracellular Traps Comprised of DNA
Due to the observation that GBS staining frequently co-
localized with PMN infiltrates, we hypothesized that GBS-
neutrophil interactions could influence the outcome of disease
progression. Specifically, it was hypothesized that neutrophils
exert an antimicrobial activity against GBS by secreting
antimicrobial molecules, such as lactoferrin. To further evaluate
this activity, ex vivo isolation of murine neutrophils was
performed and these cells were co-cultured with GBS at an
MOI of 50:1 bacterial to host cells. Co-cultures were evaluated
by high resolution microscopical techniques including high
resolution field-emission gun scanning electron microscopy
(FEG-SEM) and confocal laser scanning microscopy (CLSM).
FEG-SEM results in Figure 6 indicate that neutrophil exposure
to GBS results in enhanced neutrophil extracellular trap
formation. Similarly, confocal analyses reveal GBS-treated
samples have 24.5-fold enhanced neutrophil extracellular trap
(NET) formation compared to uninfected controls (Figure 7,
P < 0.05). These extracellular traps were ablated by treatment
of co-cultures with DNAse I, confirming that DNA is a major
component of these structures (Figures 6, 7). Furthermore,
CLSM analyses in Figure 7 in which co-cultures were stained
with Sytox Green (a non-permeant DNA stain, green) as well
as DAPI (condensed chromatin DNA stain, blue) indicated
extracellular traps, which appear to have GBS caught within their
margins, are staining Sytox Green positive, confirming these are
comprised of extracellular DNA. Conversely, uninfected controls
and DNAse I-treated GBS-neutrophil co-cultures have fewer
apparent extracellular traps staining with Sytox Green fibers
outside of the cell nucleus (P < 0.05).
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FIGURE 5 | Microscopic analyses of the spatial localization of lactoferrin within uninfected (A–D) or GBS-infected (E–H) fetal-placental tissue.
Representative micrographs collected at 4X (A,E), 20X (B,F), and 400X (C,D,G–H). Panels (A,B,D,E,F,H) indicate IHC staining with a mouse monoclonal antibody to
lactoferrin (α-Lf). Panels (C,G) indicate hematoxylin and eosin staining (H&E) for immunopathology. Panel (I) quantification of anti-lactoferrin HDAB stain by ImageJ IHC
toolbox reveals GBS infection results in elevated lactoferrin within the fetal-placental tissue (bars indicate mean quantified H-DAB stain ± SEM, P = 0.0041, Student’s
t-test, N = 3). Panels (G–H) demonstrate the preponderance of lactoferrin stain (white arrow) is associated with polymorphonuclear cells (black arrow).
FIGURE 6 | Neutrophils encountering GBS elaborate extracellular traps (NETs) comprised of extracellular DNA. High resolution scanning electron
microscopy analyses reveals murine neutrophils elaborate extracellular traps in response to GBS co-culture (B,E, white arrows), a result which was not seen in
uninfected mouse neutrophils (A,D). Treatment with DNAse I abrogates observation of extracellular traps (C,F, white arrows), indicating traps are structurally
comprised of DNA. Inset panels of (E,F) show GBS associated with NET fibers or not associated with NETs due to DNA degradation, respectively (black arrows).
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FIGURE 7 | Extracellular traps formed in response to GBS are decorated with lactoferrin. Panel (A) Confocal laser scanning microscopy analyses of
neutrophils cultured in the absence of GBS (Medium Alone), in the presence of GBS (+GBS) alone or in co-cultures supplemented with DNAse I (+GBS +DNAse I)
were subjected to intracellular nuclear DNA stain (DAPI, blue), extracellular DNA stain (Sytox, green), or antibody to lactoferrin (α-Lf). Merge images reveal that GBS
co-culture with neutrophils results in the elaboration of neutrophil extracellular traps comprised of extracellular DNA (representative images of N = 3 biological
replicates). These traps immobilize GBS (black arrow), and are studded with lactoferrin (white arrow) which is found in close contact with GBS, indicating lactoferrin is
part of the antimicrobial repertoire secreted in the NETs in response to GBS. Panel (B) Enumeration of the percentage of NETs per field was performed, and
demonstrate that NETs are enriched in GBS-containing co-cultures, but are ablated by treatment with DNAse I (Bars indicate mean percent of NETs per field ± SEM,
P < 0.0001, One Way ANOVA, N = 3 biological replicates and at least five fields per replicate, 150+ cells total).
Neutrophil Extracellular Traps Comprised
of DNA Are Studded with the Antimicrobial
Glycoprotein Lactoferrin
Previously published work indicates that lactoferrin secretion
is enhanced in gestational tissues in response to GBS infection
(Gravett et al., 2004), and that lactoferrin is a putative
antimicrobial protein which decorates the NET (Brinkmann
et al., 2004). We hypothesized that NET formation in
response to GBS exposure could result in secretion of
lactoferrin into the NET. To test this, we employed CLSM and
immunofluorescence approaches to analyze subcellular spatial
localization of lactoferrin (Figure 7, anti-lactoferrin and Alexa
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Fluor 647 conjugated secondary antibody, red) with respect
to the extracellular trap (Sytox Green, green). Our results
indicate lactoferrin secretion into the extracellular trap was
induced byGBS co-culture with PMNs. The lactoferrin associated
with extracellular DNA that comprised the NET, and was
found spatially localized near structures consistent in size and
arrangement with GBS cells, indicating lactoferrin may interact
with GBS within the NET. DNAse I treatment of the co-
culture resulted in diminished NETs observed by CLSM, and this
treatment also resulted in decreased extracellular lactoferrin and
GBS-associated with PMNs, indicating lactoferrin was associated
with the DNAwhich structurally comprises the extracellular trap,
and that the NETs potentially served to immobilize GBS and
expose them to antimicrobial insults including lactoferrin.
Lactoferrin Exerts Antimicrobial Activity
against GBS via Iron Sequestration
Because lactoferrin is an antimicrobial glycoprotein that binds
and sequesters iron in a strategy to chelate nutrient iron
away from invading microorganisms, we hypothesized that the
deposition of lactoferrin within neutrophil extracellular traps
could potentially inhibit GBS growth and viability. To test this,
bacterial growth and viability assays were performed. Results in
Figure 8 indicate that at concentrations of 100, 250, 500, 750, and
1000 µg/mL, apo-lactoferrin represses GBS growth 46, 50, 95,
91, and 94%, respectively, compared to cells cultured in medium
alone. This result was recapitulated using the synthetic iron
chelator 2, 2′ dipyridyl which has antimicrobial activity against
GBS (Supplemental Figure 4). Interestingly, supplementation
with 100 µM ferric chloride as an exogenous source of nutrient
iron restored bacterial cell density to levels that were comparable
or higher than those grown in medium alone (Figure 8,
Supplemental Figure 4). Results in Figure 8 indicated that even
at concentrations as high as 1000 µg/mL, holo-lactoferrin did
not repress bacterial growth significantly compared to medium
alone, a result that could be attributed to the fact that the iron-
loaded form of this protein did not exert iron chelation activity
on the bacteria within this particular growth medium. Taken
together, these results indicate that the iron-sequestration activity
of apo-lactoferrin has detrimental effects on GBS; diminishing
both bacterial growth and viability through micronutrient
starvation.
DISCUSSION
GBS Invades Reproductive Tissues,
Crosses the Placenta, and Disseminates to
the Fetus
Colonization of the vaginal mucosa is a critical primary
step in GBS pathogenesis during pregnancy. Once colonized,
bacteria ascend into the intrauterine cavity, transverse the
fetal membranes, and cause severe neonatal disease outcomes
including preterm birth, neonatal sepsis, and neonatal demise.
The advent of a model of ascending GBS infection in a
pregnant mouse provides numerous genetic and immunological
tools to study the complex dialogue between host and
FIGURE 8 | Analysis of bacterial viability after 24 h of culture. Exposure
to apo-lactoferrin (Apo-Lf, open squares) results in decreased GBS growth
and viability in a dose-dependent manner, a result which was reversed by the
addition of a source of exogenous nutrient iron (closed circles). Conversely,
exposure to increasing concentrations of holo-lactoferrin (Holo-Lf, closed
diamonds) does not significantly inhibit bacterial viability. Points indicate mean
CFU/mL ± SEM per timepoint (N = 3 biological replicates). *P < 0.05,
compared to Medium + Iron plus Apo-Lf, ≈P < 0.05, compared to Medium
plus Holo-Lf.
pathogen during pregnancy (Randis et al., 2014). We have
further refined this model by dissecting the gestational tissue
compartments and analyzing both enumeration of GBS burden
and spatial distribution of bacteria by quantitative culture and
immunohistochemical techniques. These experiments reveal that
bacterial invasion could be observed in the vagina, uterus,
decidua, placenta, and fetus with the highest burden being
present in the uterus and the burden titrating as the bacteria
penetrate the gravid host, as is expected in a model of
invasion.
The Murine Model of Ascending Vaginal
Infection by GBS Results in
Chorioamnionitis Which Is Characterized
by a Profound Infiltration of PMNs to the
Choriodecidua and Placenta
In response to GBS infection, pro-inflammatory signaling
cascades are promoted which ultimately lead to the recruitment
of innate immune cells to the site of infection (Randis et al.,
2014). Concordant with this, our work demonstrates that GBS
infection elicits significant PMN recruitment to the placenta
(2.5-fold increase compared to uninfected controls) and the
decidua (3.3-fold increase compared to uninfected controls),
a result that is in agreement with experiments performed in
previous studies using this model indicating inflammation-
related pathology scores are elevated in GBS-infected animals
compared to sham-treated controls (Randis et al., 2014). It
is interesting to note that the neutrophilic infiltrate within
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the gestational tissues mirrors the clinical presentation of
chorioamnionitis in human subjects (McNamara et al., 1997;
Gravett et al., 2004; Goldenberg et al., 2008). This neutrophil
response likely initiates an antimicrobial response, through
phagocytosis and bacterial killing, as well as through the
deposition of antimicrobial molecules at the site of infection.
Furthermore, it is likely that neutrophil presence results in
the stimulation of pro-inflammatory signaling cascades which
initiates further inflammation pathways leading to perturbed
maternal-fetal tolerance and tissue destruction (Marzano et al.,
2010; Simard et al., 2011; PrabhuDas et al., 2015; Tsatsaronis et al.,
2015).
Murine PMNs Form NETs in Response to
GBS
Neutrophils play a critical role in controlling invading pathogens
(Kobayashi and DeLeo, 2009). Emerging evidence indicates that
one pathway neutrophils employ to combat pathogenic microbes
is elaboration of NETs (Brinkmann et al., 2004). NETs function
as a structural component of the innate immune response
which serves to immobilize microorganisms (Brinkmann et al.,
2004). NETs are largely comprised of DNA and associated
histones which are decorated with antimicrobial molecules
(Brinkmann et al., 2004; Urban et al., 2006). Because NETs can
immobilize bacteria, bringing them into intimate contact with
these antimicrobial proteins and glycoproteins, it is purported
that NETs are an important arm of the antimicrobial defense
strategies employed by the host (Brinkmann et al., 2004; Urban
et al., 2006).
Our work indicates murine neutrophils deploy extracellular
traps in response to encountering GBS. Previous work has shown
that GBS-infected human tissues have abundant neutrophilic
infiltrates and GBS induces NETosis in human neutrophils
as determined by immunohistochemical and microscopical
analyses using neutrophil elastase and histones, markers which
are commonly associated with NETs (Carlin et al., 2009; Derré-
Bobillot et al., 2013; Yan et al., 2013; Moon et al., 2014;
Okumura and Nizet, 2014; Xu et al., 2015). Interestingly,
work by Carey et al. shows that induction of NETosis is
hemolysin-dependent, indicating that GBS virulence factors
participate in this process (Carey et al., 2014). Derre-Bobillot
et al., report that GBS encodes a DNAse which is critical for
liberating the bacterial cell from the murine NET, indicating
GBS has mechanisms to evade this immunological response
(Derré-Bobillot et al., 2013). It is worthy to note that in
this report, the authors utilized murine PMNs which were
elicited by thioglycollate treatment and subsequently stimulated
with PMA (Phorbol-12-Myristate-13-Acetate) to induce murine
NET formation. Murine NETs induced during co-culture with
GBS are comprised of extracellular DNA, a result which
agrees with previously published reports (Brinkmann et al.,
2004; Carey et al., 2014). Our approach to studying GBS-
dependent induction of NET formation has been employed
by other groups utilizing extracellular DNA stains such as
Sytox Green, or the biochemical approach of DNAse-dependent
degradation of NETs to determine the association of extracellular
DNA with NET structures (Carlin et al., 2009; Yan et al.,
2013).
NETs Induced by GBS Contain Lactoferrin
It is increasingly appreciated that NETs are reservoirs of
antimicrobial molecules (Brinkmann et al., 2004; Jean et al.,
2016). A wide repertoire of antimicrobial molecules including
calprotectin, lactoferrin, and cathelicidin has been associated
with NETs (Bennike et al., 2015). Many of these have
been identified by unbiased proteomics techniques, targeted
immunohistochemical techniques, and microbiological killing
assays. These antimicrobial molecules are important mediators of
innate immunity. Interestingly, both calprotectin and lactoferrin
participate in chelation of nutrient metals, a process that
effectively sequesters transition metals away from pathogenic
microbes (Becker and Skaar, 2014; Gaddy et al., 2014).
Nutritional immunity is progressively recognized as a critical way
to combat microbial infection (Becker and Skaar, 2014; Gaddy
et al., 2014; Haley et al., 2015). Lactoferrin is of particular interest
as GBS induces elevated lactoferrin levels during infection of
placental membranes, however the cellular contribution for this
was obscure (Boldenow et al., 2013). Furthermore, elevated
lactoferrin levels have been associated with GBS infection in
neonates such as septicemia (Gutteberg et al., 1990, 1991).
We report that GBS-induced NETs are a source of lactoferrin,
however the role of these structures and antimicrobial molecules
in the context of infection during pregnancy remains unknown.
FIGURE 9 | Conceptual diagram of the murine model of GBS infection
during pregnancy. Results derived from in vivo and ex vivo experiments
reveal GBS has the capacity to cause ascending vaginal infection during
pregnancy, induction of neutrophil recruitment to invaded tissues, and that
GBS-neutrophil interactions promote extracellular trap formation and
deposition of antimicrobial molecules (such as lactoferrin) that promote
nutritional immunity.
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Lactoferrin Has Antimicrobial Activities
against GBS
Lactoferrin is a neutrophil-associated glycoprotein with
immunomodulatory properties which has long been recognized
as a broad-spectrum antimicrobial agent against numerous
microorganisms (Arciola, 2010; Savchenko et al., 2011;
Scapinello et al., 2011; Svobodová et al., 2012; Barrientos
et al., 2013; Björnsdottir et al., 2016; Carretta et al., 2016;
Feintuch et al., 2016; Okubo et al., 2016; van der Spek et al.,
2016). This activity is associated with lactoferrin’s intrinsic iron-
binding properties which participate in nutritional immunity
via iron sequestration (Weinberg, 1975, 1977; Bezkorovainy,
1981; Ellison, 1994). Iron is a strict nutritional requirement
for numerous bacteria including GBS, thus chelation of this
critical molecule could alter bacterial cell biology (Mickelson,
1966; Willett and Morse, 1966). Our results indicate that apo-
lactoferrin at 100, 250, 500, 750, 1000 ug/mL resulted in 1.8, 2.0,
19.6, 10.9, 16.7-fold, decreased bacterial viability, respectively.
Work by other groups indicates bovine lactoferrin has been
demonstrated to have bacteriostatic activity against GBS, and
human lactoferrin has been observed to bind to lipoteichoic acids
in Streptococcus spp., inhibit biofilm formation, and activate
the complement pathway, indicating it has immunomodulatory
and pleotropic effects (Rainard, 1986, 1993; Berlutti et al., 2004;
Andréa et al., 2015). Interestingly, lactoferrin administration
as a prebiotic is under consideration for women with preterm
delivery and lactoferrin supplementation to formula has been
shown to limit GBS growth >50% (Otsuki et al., 2014; Trend
et al., 2015).
CONCLUSIONS
In conclusion, we report that a pregnant mouse model of
ascending GBS vaginal infection results in bacterial colonization
of the reproductive tract and invasion of the placenta,
decidua and fetus (See Figure 9). As a consequence of GBS
invasion, neutrophils are recruited to the placental and decidual
compartments; likely as a host strategy to contain the infection.
In response to GBS infection, lactoferrin is elevated within
the placental and decidual tissue. Furthermore, ex vivo results
indicate neutrophils elaborate extracellular traps decorated with
lactoferrin upon encountering GBS. Lactoferrin can subsequently
exert an antimicrobial activity in vitro against GBS via chelation
of nutrient iron, which is required for GBS growth and
viability. Thus, a better understanding of lactoferrin deposition
by neutrophils in NETs and the interplay of this important
host molecule with GBS could lead to novel chemotherapeutic
strategies as the utility of antibiotics wanes.
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Supplemental Figure 1 | Immunohistochemical and immunopathological
analyses of uninfected or GBS-infected vaginal muscularis and mucosal
tissue. Immunopathological examination by hematoxylin and eosin staining (H&E)
reveal neutrophils at the surface of the mucosa (black arrows, inset panel of
GBS-infected tissue micrograph), which corresponds to an area within the
mucosa that is colonized by GBS as determined by immunohistochemical staining
with a polyclonal rabbit antibody to GBS (white arrows, inset panel of
GBS-infected tissue micrograph), a result that was not observed in uninfected
tissue (Uninfected).
Supplemental Figure 2 | Immunohistochemical and immunopathological
analyses of uninfected or GBS-infected uterine tissue (myometrium,
endometrium, and lumen). Immunopathological examination by hematoxylin
and eosin staining (H&E) reveal preserved tissue architecture in both uninfected
and GBS-infected animals. However, immunohistochemical staining indicates
GBS colonizes the lumen and the surface of the endometrium as determined by
staining with a polyclonal rabbit antibody to GBS (white arrows, inset panel of
GBS-infected tissue micrograph), a result that was not observed in uninfected
tissue (Uninfected).
Supplemental Figure 3 | Gating strategy for flow cytometry analyses of
neutrophils isolated from mouse reproductive tissues. Neutrophils were
stained with antibodies specific to 1A8 GR1 clone (Ly6g), CD45, and Neu7/4, and
analyzed by flow cytometry using a gating strategy to quantify cells defined as
Neu7/4high, GR1high within the viable CD45+ cells (27.9% of Viable CD45+
cells). In comparison, similar results were obtained when neutrophils were stained
with antibodies specific to 1A8 GR1 clone (Ly6g), CD45, and CD11b, and
analyzed by flow cytometry using a gating strategy to quantify cells defined as
CD11bhigh, GR1high within the viable CD45+ cells (29.8% of Viable CD45+ cells).
Supplemental Figure 4 | Iron chelation inhibits GBS growth.
Spectrophotometric analyses reveal increasing concentrations of the synthetic iron
chelator 2, 2′ dipyridyl (Dipyridyl) repress GBS cell density in medium alone
(Medium Alone) after 24 h of culture. Supplementation with excess exogenous
nutrient iron (250 µM ferric chloride, Medium + Iron) restores bacterial growth in
the presence of the synthetic chelator (P < 0.05, Student’s t-test comparing
medium alone to medium + iron), indicating iron is a critical micronutrient for GBS
growth and proliferation.
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